Archive for the 'Ovarian Cancer'

CK5 marks cisplatin-resistant ovarian cancer

A University of Colorado Cancer Center study recently published in the International Journal of Gynecological Cancer shows that protein cytokeratin 5 (CK5), known to be a marker of poor prognosis in...

Why are many women at risk of ovarian cancer not aware of it?

The color teal in September represents Ovarian Cancer Awareness Month. This may be the most difficult women's cancer to detect and treat, yet many women are unaware of the risks.

Promising results for peptide SOR-C13

Soricimed Biopharma Inc. are pleased to announce details of two posters that were presented at The Essential Protein Engineering Summit (PEGS), in Boston, showing promising results for the SOR-C13.

Some ovarian and breast cancer patients may benefit from manipulation of a non-coding microRNA

A genetic misfire called the 3q26.2 amplicon can cause real havoc. In fact, it is among the most frequent chromosomal aberrations seen in many cancers, including ovarian and breast cancers.

Promising treatment option and improved survival rates for patients with ovarian, breast, pancreatic, and prostate cancers

Olaparib, an experimental twice-daily oral cancer drug, produces an overall tumor response rate of 26 percent in several advanced cancers associated with BRCA1 and BRCA2 mutations, according to new...